Molecular imaging biomarkers of resistance to radiation therapy for spontaneous nasal tumors in canines.
暂无分享,去创建一个
Robert Jeraj | Stephen R Bowen | Søren M Bentzen | R. Jeraj | L. Forrest | S. Bentzen | S. Bowen | T. Bradshaw | R. Chappell | Tyler J Bradshaw | Michael A Deveau | Lyndsay Kubicek | Pamela White | Richard J Chappell | Lisa J Forrest | M. Deveau | L. Kubicek | Pamela White
[1] Robert J Myerson,et al. Tumor Hypoxia Detected by Positron Emission Tomography with 60Cu-ATSM as a Predictor of Response and Survival in Patients Undergoing Neoadjuvant Chemoradiotherapy for Rectal Carcinoma: A Pilot Study , 2008, Diseases of the colon and rectum.
[2] Jung-Tung Liu,et al. The role of pretreatment FDG-PET in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. , 2012, International journal of radiation oncology, biology, physics.
[3] R. Jeraj,et al. Heterogeneity in Intratumor Correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in Canine Sinonasal Tumors , 2013, The Journal of Nuclear Medicine.
[4] J. Passchier,et al. A Comparison of the Behavior of 64Cu-Acetate and 64Cu-ATSM In Vitro and In Vivo , 2014, The Journal of Nuclear Medicine.
[5] C. Khanna,et al. Spontaneous and genetically engineered animal models; use in preclinical cancer drug development. , 2004, European journal of cancer.
[6] Veerle Kersemans,et al. Hypoxia Imaging Using PET and SPECT: The Effects of Anesthetic and Carrier Gas on [64Cu]-ATSM, [99mTc]-HL91 and [18F]-FMISO Tumor Hypoxia Accumulation , 2011, PloS one.
[7] C. Faivre-Finn,et al. Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[8] D. Brizel,et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] R. Jeraj,et al. Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy. , 2014, International journal of radiation oncology, biology, physics.
[10] P Peduzzi,et al. Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. , 1995, Journal of clinical epidemiology.
[11] David L. Schwartz,et al. Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer , 2006, Clinical Cancer Research.
[12] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[13] J C Horiot,et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] Sen Zhao,et al. Prognostic Factors for Local Control in Non–Small-Cell Lung Cancer Treated With Definitive Radiation Therapy , 2002, American journal of clinical oncology.
[15] R. Dodge,et al. Factors influencing survival after radiotherapy of nasal tumors in 130 dogs. , 1999, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[16] Jean-Emmanuel Bibault,et al. Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review , 2013, Cancer and Metastasis Reviews.
[17] D. Heron,et al. Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy , 2014, Radiation Oncology.
[18] J. Concato,et al. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. , 1995, Journal of clinical epidemiology.
[19] Jin-Sook Ryu,et al. [18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung , 2008, Clinical Cancer Research.
[20] N. Demirci,et al. High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size , 2014, Journal of Cancer Research and Clinical Oncology.
[21] Ingeborg Goethals,et al. Nuclear medicine imaging to predict response to radiotherapy: a review. , 2003, International journal of radiation oncology, biology, physics.
[22] R. Jeraj,et al. Helical tomotherapy setup variations in canine nasal tumor patients immobilized with a bite block. , 2012, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[23] E. Hall,et al. Radiobiology for the Radiologist, 6th Edition , 2006 .
[24] W. Oyen,et al. 18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors , 2010, Journal of Nuclear Medicine.
[25] R. Jeraj,et al. Heterogeneity in stabilization phenomena in FLT PET images of canines , 2014, Physics in medicine and biology.
[26] J. Yoon,et al. External-beam Co-60 radiotherapy for canine nasal tumors: a comparison of survival by treatment protocol. , 2008, Research in veterinary science.
[27] M. Green,et al. Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects. , 2009, Nuclear medicine and biology.
[28] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[29] M Van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.
[30] Steen Jakobsen,et al. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] J. Bussink,et al. 64Cu-ATSM and 18FDG PET uptake and 64Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry , 2012, Radiation oncology.
[32] Paul J. van Diest,et al. Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography , 2002 .
[33] Mark A Mintun,et al. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. , 2003, International journal of radiation oncology, biology, physics.
[34] D. Cox,et al. The analysis of binary data , 1971 .
[35] G. Watkins,et al. Kinetic Analysis of 3′-Deoxy-3′-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy , 2009, Journal of Nuclear Medicine.
[36] R. Boellaard,et al. Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Carsten Brink,et al. Locoregional control of non-small cell lung cancer in relation to automated early assessment of tumor regression on cone beam computed tomography. , 2014, International journal of radiation oncology, biology, physics.
[38] Tomio Inoue,et al. Assessment of tumor hypoxia by 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study , 2011, Annals of nuclear medicine.
[39] Luc Thiberville,et al. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] L. Forrest,et al. Prognostic significance of tumor histology and computed tomographic staging for radiation treatment response of canine nasal tumors. , 2009, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[41] T. Björk-Eriksson,et al. Comparison of predicted and clinical response to radiotherapy: A radiobiology modelling study , 2009, Acta oncologica.
[42] I. Tannock,et al. Repopulation of cancer cells during therapy: an important cause of treatment failure , 2005, Nature Reviews Cancer.
[43] M. Schwaiger,et al. PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[44] Mohamed Allaoua,et al. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. , 2004, International journal of radiation oncology, biology, physics.
[45] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[46] B. Hoeben,et al. 18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome , 2013, The Journal of Nuclear Medicine.
[47] Michael J. Welch,et al. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[48] P. V. van Diest,et al. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] Richard Laforest,et al. Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone) , 2008, Journal of Nuclear Medicine.